0001104659-20-033412.txt : 20200313
0001104659-20-033412.hdr.sgml : 20200313
20200313190447
ACCESSION NUMBER: 0001104659-20-033412
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200312
FILED AS OF DATE: 20200313
DATE AS OF CHANGE: 20200313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rolph Timothy
CENTRAL INDEX KEY: 0001779479
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 20714710
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 170 HARBOR WAY, 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
a4.xml
4
X0306
4
2020-03-12
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001779479
Rolph Timothy
C/O AKERO THERAPEUTICS, INC.
170 HARBOR WAY, 3RD FLOOR
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
Common Stock
2020-03-12
4
M
0
27368
0.61
A
220277
D
Common Stock
2020-03-12
4
M
0
22656
0.61
A
242933
D
Stock Option (Right to Buy)
0.61
2020-03-12
4
M
0
27368
0
D
2028-10-17
Common Stock
27368
94268
D
Stock Option (Right to Buy)
0.61
2020-03-12
4
M
0
22656
0
D
2028-07-29
Common Stock
22656
42796
D
Shares vested and became exercisable in equal monthly installments for a period of 48 months following October 1, 2018.
25% of this option vested on August 1, 2018 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.
/s/ Jonathan Young, Attorney-in-Fact
2020-03-13